SCHEMBL5723136

SCHEMBL5723136

COc1ccc(C(=O)O)c2c1OCC2C(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.43
ALDH1A1 P00352 5/20 0.43
HSD17B10 Q99714 3/20 0.43
LMNA P02545 2/20 0.43
MAPT P10636 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
CDC25B P30305 1/20 0.36
KMT2A Q03164 1/20 0.36
MAPK1 P28482 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
APEX1 P27695 1/20 0.34
HPGD P15428 2/20 0.34
HTT P42858 1/20 0.34
MYC P01106 1/20 0.34
APAF1 O14727 1/20 0.34
RECQL P46063 1/20 0.34
CASP6 P55212 1/20 0.34
CACNA1B Q00975 1/20 0.34
APBA1 Q02410 1/20 0.34
MCL1 Q07820 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5723212 0.82 KDM4E (0.47) KDM4EALDH1A1HSD17B10LMNAMAPT
SCHEMBL5722912 0.78 KDM4E (0.43) KDM4EALDH1A1HSD17B10LMNAMAPT
SCHEMBL5723024 0.77 PDE4D (0.55)
SCHEMBL5723139 0.76 KDM4E (0.42) KDM4EALDH1A1HSD17B10LMNAMAPT
SCHEMBL5228868 0.74 KDM4E (0.40) KDM4EALDH1A1HSD17B10LMNAMAPT
SCHEMBL23841346 0.74 PPARG (0.40) ALDH1A1HSD17B10MAPK1HPGDNPC1
SCHEMBL5723699 0.73 LMNA (0.39) KDM4EALDH1A1HSD17B10LMNAMAPT
SCHEMBL20480189 0.71 KDM4E (0.43) KDM4EALDH1A1HSD17B10LMNAMAPT
SCHEMBL6837800 0.71 KDM4E (0.67) KDM4EALDH1A1HSD17B10LMNAMAPT
SCHEMBL857118 0.71 KDM4E (0.67) KDM4EALDH1A1HSD17B10LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0771794-B1 OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS KYOWA HAKKO KOGYO KK (JP) 2006-05-03 EP disclosed
US-6716987-B1 PHOSPHODIESTERASE IV INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-04-06 US disclosed
US-6514996-B2 Derivatives of benzofuran or benzodioxole KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-02-04 US disclosed
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-09-12 US disclosed
EP-0771794-A1 OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS KYOWA HAKKO KOGYO CO., LTD. (JP) 1997-05-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE CBR1, CBR3, CYC1 KDM4E 3975/4885ALDH1A1 323/4885HSD17B10 153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.